nEw3 Post-approval Study

Mise à jour : Il y a 4 ans
Référence : NCT01076374

Femme et Homme

Extrait

The primary purpose of this study is to assess the long term reliability of the Medtronic Adapta®/Sensia™/Versa™ platform of devices. This study is required by FDA as a condition of approval of nEw3 devices. Patients will be followed for 5 years after implant. This study utilizes data collected from the System Longevity Study (SLS).


Critère d'inclusion

  • Arrhythmia ,Bradycardia


Liens